Action State Street SPDR S&P Te...

State Street SPDR S&P Telecom ETF (XTL) Action

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

216,66

( 0,52% )

Prix Achat

Prix Vente

Volume échangé

94 132

212,00 Fourchette du Jour 217,35

114,88 Plage de 52 semaines 247,62

Clôture Veille

215,54

Ouverture

212,74

Dernière Transaction

220.2

Dernière heure de transaction

01:14:23

Volume moyen (3 m)

115 537

Volume financier

US$ 20 281 564

VWAP

215,4588

The Comprehensive Guide to Telecom ETFs - ETF News And Commentary

The telecommunications industry is identified as a major driver of global economic recovery. Unprecedented growth in high-speed mobile Internet...

Comprehensive Guide to Telecom ETFs - ETF News And Commentary

Despite the lingering economic woes, the global telecom industry has nicely held up this year thanks to healthy growth and its traditional role...

U.S. Telecom ETFs: Opportunities and Threats - ETF News And Commentary

TELECOM ETFs Despite the sluggish economy, stiff competition and stringent regulations, the U.S. telecom service providers are delivering...

Are Telecom ETFs In Trouble? - ETF News And Commentary

Although the American economy appears to be picking up steam, earnings reports in some industries have failed to keep pace. A variety of...

XTL Biopharmaceuticals Provides Update on Potential Strategic Alternatives

VALLEY COTTAGE, N.Y., Jan. 28 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLBNASDAQ:TASE:NASDAQ:XTL) today announced an...

XTLbio Announces Grant of hMAb Patent

XTLbio Announces Grant of Human Monoclonal Antibody Patent Patent Covers Antibodies Directed Against Hepatitis B Virus Surface Antigen Rehovot...

XTLbio appoints Stockbroker and Financial Adviser

XTLbio appoints Stockbroker and Financial Adviser Rehovot, 20 January 2004 - The Board of XTL Biopharmaceuticals Ltd ("XTLbio" or the "Company...

XTLbio announces appointment of Non-Executive Director

XTLbio announces appointment of Non-Executive Director Rehovot, 12 January 2004 - XTL Biopharmaceuticals Ltd. (LSE:XTL) is pleased to announce the...

Business Update

RNS Number:2908T XTL Biopharmaceuticals Limited 16 December 2003 XTLbio R&D and Business Development Update Rehovot, Israel, 16 December...

XTLbio R&D and Business Development Update

XTLbio R&D and Business Development Update Rehovot, Israel, 16 December 2003 - XTL Biopharmaceuticals Ltd (XTLbio) today announces an update on...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-2.43	-1.10913323292	219.09	222.75	212.29	86188	217.98075132	SP
4	-22.89	-9.55541640576	239.55	247.62	212.29	136651	228.66789849	SP
12	17.17	8.60694771668	199.49	247.62	196.26	115537	223.1133166	SP
26	60.93	39.1254093624	155.73	247.62	152.75	77998	210.1970901	SP
52	101.34	87.8772112383	115.32	247.62	114.88	46188	198.73532975	SP
156	143.66	196.794520548	73	247.62	64.09	21386	168.47001212	SP
260	111.75	106.519874178	104.91	247.62	64.09	15362	154.97575971	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

State Street SPDR S&P Telecom ETF (XTL)